Phenotypic and genotypic characterization of Hodgkin's disease

P. R K Koduru, M. Susin, P. Schulman, D. Catell, J. C. Goh, L. Karp, J. D. Broome

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Although a few studies have reported clonal cytogenetic changes in Hodgkin's disease (HD), their correlation with histologic groups is poorly defined. This is because of insufficient numbers of clonally abnormal cases ascertained in each of these studies, an inherent problem associated with the cytogenetic studies of HD. In this report we present results of pathologic, phenotypic, and genetic studies on 29 HD tumors consecutively ascertained by us and the results of a comprehensive analysis of the cytogenetic data available in the literature. In our series 75% of the tumors were positive for Epstein-Barr virus (EBV) by polymerase chain reaction (PCR) assay. A higher frequency of EBV-positive tumors showed clonal karyotypic abnormalities than the EBV-negative tumors. Unlike the case in the previous reports, none of the 24 tumors studied by PCR showed the presence of t(14;18) (q32;q21)-carrying cells. From the comprehensive analysis of the literature, we identified recurring nonrandom numerical changes, deletions, and chromosome breaks in HD. Some of these are associated either with nodular sclerosis or with mixed cellular histologies. A comparison of the pattern of these nonrandom cytogenetic changes in HD and those reported for non-Hodgkin's lymphomas (NHL) identified common deletions and breaks between them. These common genetic lesions probably play a role in disease evolution.

Original languageEnglish (US)
Pages (from-to)117-124
Number of pages8
JournalAmerican Journal of Hematology
Volume44
Issue number2
StatePublished - 1993

Fingerprint

Hodgkin Disease
Human Herpesvirus 4
Cytogenetics
Neoplasms
Chromosome Breakage
Polymerase Chain Reaction
Cytogenetic Analysis
Sclerosis
Non-Hodgkin's Lymphoma
Histology

Keywords

  • cytogenetics
  • histologic correlations
  • Hodgkin's disease
  • molecular genetics

ASJC Scopus subject areas

  • Hematology

Cite this

Koduru, P. R. K., Susin, M., Schulman, P., Catell, D., Goh, J. C., Karp, L., & Broome, J. D. (1993). Phenotypic and genotypic characterization of Hodgkin's disease. American Journal of Hematology, 44(2), 117-124.

Phenotypic and genotypic characterization of Hodgkin's disease. / Koduru, P. R K; Susin, M.; Schulman, P.; Catell, D.; Goh, J. C.; Karp, L.; Broome, J. D.

In: American Journal of Hematology, Vol. 44, No. 2, 1993, p. 117-124.

Research output: Contribution to journalArticle

Koduru, PRK, Susin, M, Schulman, P, Catell, D, Goh, JC, Karp, L & Broome, JD 1993, 'Phenotypic and genotypic characterization of Hodgkin's disease', American Journal of Hematology, vol. 44, no. 2, pp. 117-124.
Koduru PRK, Susin M, Schulman P, Catell D, Goh JC, Karp L et al. Phenotypic and genotypic characterization of Hodgkin's disease. American Journal of Hematology. 1993;44(2):117-124.
Koduru, P. R K ; Susin, M. ; Schulman, P. ; Catell, D. ; Goh, J. C. ; Karp, L. ; Broome, J. D. / Phenotypic and genotypic characterization of Hodgkin's disease. In: American Journal of Hematology. 1993 ; Vol. 44, No. 2. pp. 117-124.
@article{ab676bda47c845beb67e2d6ee34472c0,
title = "Phenotypic and genotypic characterization of Hodgkin's disease",
abstract = "Although a few studies have reported clonal cytogenetic changes in Hodgkin's disease (HD), their correlation with histologic groups is poorly defined. This is because of insufficient numbers of clonally abnormal cases ascertained in each of these studies, an inherent problem associated with the cytogenetic studies of HD. In this report we present results of pathologic, phenotypic, and genetic studies on 29 HD tumors consecutively ascertained by us and the results of a comprehensive analysis of the cytogenetic data available in the literature. In our series 75{\%} of the tumors were positive for Epstein-Barr virus (EBV) by polymerase chain reaction (PCR) assay. A higher frequency of EBV-positive tumors showed clonal karyotypic abnormalities than the EBV-negative tumors. Unlike the case in the previous reports, none of the 24 tumors studied by PCR showed the presence of t(14;18) (q32;q21)-carrying cells. From the comprehensive analysis of the literature, we identified recurring nonrandom numerical changes, deletions, and chromosome breaks in HD. Some of these are associated either with nodular sclerosis or with mixed cellular histologies. A comparison of the pattern of these nonrandom cytogenetic changes in HD and those reported for non-Hodgkin's lymphomas (NHL) identified common deletions and breaks between them. These common genetic lesions probably play a role in disease evolution.",
keywords = "cytogenetics, histologic correlations, Hodgkin's disease, molecular genetics",
author = "Koduru, {P. R K} and M. Susin and P. Schulman and D. Catell and Goh, {J. C.} and L. Karp and Broome, {J. D.}",
year = "1993",
language = "English (US)",
volume = "44",
pages = "117--124",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Phenotypic and genotypic characterization of Hodgkin's disease

AU - Koduru, P. R K

AU - Susin, M.

AU - Schulman, P.

AU - Catell, D.

AU - Goh, J. C.

AU - Karp, L.

AU - Broome, J. D.

PY - 1993

Y1 - 1993

N2 - Although a few studies have reported clonal cytogenetic changes in Hodgkin's disease (HD), their correlation with histologic groups is poorly defined. This is because of insufficient numbers of clonally abnormal cases ascertained in each of these studies, an inherent problem associated with the cytogenetic studies of HD. In this report we present results of pathologic, phenotypic, and genetic studies on 29 HD tumors consecutively ascertained by us and the results of a comprehensive analysis of the cytogenetic data available in the literature. In our series 75% of the tumors were positive for Epstein-Barr virus (EBV) by polymerase chain reaction (PCR) assay. A higher frequency of EBV-positive tumors showed clonal karyotypic abnormalities than the EBV-negative tumors. Unlike the case in the previous reports, none of the 24 tumors studied by PCR showed the presence of t(14;18) (q32;q21)-carrying cells. From the comprehensive analysis of the literature, we identified recurring nonrandom numerical changes, deletions, and chromosome breaks in HD. Some of these are associated either with nodular sclerosis or with mixed cellular histologies. A comparison of the pattern of these nonrandom cytogenetic changes in HD and those reported for non-Hodgkin's lymphomas (NHL) identified common deletions and breaks between them. These common genetic lesions probably play a role in disease evolution.

AB - Although a few studies have reported clonal cytogenetic changes in Hodgkin's disease (HD), their correlation with histologic groups is poorly defined. This is because of insufficient numbers of clonally abnormal cases ascertained in each of these studies, an inherent problem associated with the cytogenetic studies of HD. In this report we present results of pathologic, phenotypic, and genetic studies on 29 HD tumors consecutively ascertained by us and the results of a comprehensive analysis of the cytogenetic data available in the literature. In our series 75% of the tumors were positive for Epstein-Barr virus (EBV) by polymerase chain reaction (PCR) assay. A higher frequency of EBV-positive tumors showed clonal karyotypic abnormalities than the EBV-negative tumors. Unlike the case in the previous reports, none of the 24 tumors studied by PCR showed the presence of t(14;18) (q32;q21)-carrying cells. From the comprehensive analysis of the literature, we identified recurring nonrandom numerical changes, deletions, and chromosome breaks in HD. Some of these are associated either with nodular sclerosis or with mixed cellular histologies. A comparison of the pattern of these nonrandom cytogenetic changes in HD and those reported for non-Hodgkin's lymphomas (NHL) identified common deletions and breaks between them. These common genetic lesions probably play a role in disease evolution.

KW - cytogenetics

KW - histologic correlations

KW - Hodgkin's disease

KW - molecular genetics

UR - http://www.scopus.com/inward/record.url?scp=0027169549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027169549&partnerID=8YFLogxK

M3 - Article

C2 - 8266916

AN - SCOPUS:0027169549

VL - 44

SP - 117

EP - 124

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 2

ER -